Xcell biosciences announces joint research collaboration with thermo fisher scientific to advance the next generation of cell therapies

San francisco--(business wire)--xcell biosciences (xcellbio), a san francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration with thermo fisher scientific inc., the world leader in serving science, to advance research in regulatory t cells (tregs) and tumor-infiltrating lymphocytes (tils). while significant progress has been made in the cell therapy space leveraging chimeric antigen receptor t (car t) cells, this collaborat.
TMO Ratings Summary
TMO Quant Ranking